tiprankstipranks
Trending News
More News >
Mineralys Therapeutics, Inc. (MLYS)
:MLYS
US Market

Mineralys Therapeutics, Inc. (MLYS) Similar Stocks

Compare
419 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mineralys Therapeutics, Inc.
$13.73
$898.12M
16.45%
6 Buy
1 Hold
0 Sell
Strong Buy
Chimerix
$8.54
$801.08M
881.61%
1 Buy
3 Hold
0 Sell
Hold
Spyre Therapeutics
$15.08
$916.17M
2.31
-41.53%
8 Buy
1 Hold
0 Sell
Strong Buy
Vir Biotechnology
$5.21
$705.01M
-41.79%
7 Buy
2 Hold
0 Sell
Strong Buy
89bio
$10.00
$1.47B
19.05%
3 Buy
1 Hold
0 Sell
Strong Buy
Enliven Therapeutics
$21.57
$1.07B
5.37%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLYS
Mineralys Therapeutics, Inc.
13.73
2.02
17.25%
CMRX
Chimerix
8.54
7.65
859.55%
SYRE
Spyre Therapeutics
15.08
-10.55
-41.16%
VIR
Vir Biotechnology
5.21
-3.74
-41.79%
ETNB
89bio
10.00
2.07
26.10%
ELVN
Enliven Therapeutics
21.57
0.53
2.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis